Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafna M Abelson

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Science (New York, N.Y.)|November 18, 2021
Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodiesAkaash K Mishra, Jan Hellert, Natalia Freitas, et al.
Journal of Virology|January 31, 2020
Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38Akaash K Mishra, Crystal L Moyer, Dafna M Abelson, et al.
Nature Communications|March 26, 2021
Combination therapy protects macaques against advanced Marburg virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spreadFelix Pahmeier, Stephanie R Monticelli, Xinyi Feng, et al.
Pathogens (Basel, Switzerland)|June 24, 2022
Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus ImmunotherapeuticErin Kuang, Robert W Cross, Maria McCavitt-Malvido, et al.
Science Translational Medicine|February 19, 2025
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spreadFelix Pahmeier, Stephanie R Monticelli, Xinyi Feng, et al.
Mbio|April 16, 2025
Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virusAlbert Wang, Stephanie R Monticelli, Ariel S Wirchnianski, et al.
JCI Insight|April 12, 2022
Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Science Translational Medicine|April 3, 2024
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primatesLarry Zeitlin, Robert W Cross, Courtney Woolsey, et al.
Plos Pathogens|April 11, 2024
Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodiesAriel S Wirchnianski, Elisabeth K Nyakatura, Andrew S Herbert, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Science (New York, N.Y.)|November 18, 2021
Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodiesAkaash K Mishra, Jan Hellert, Natalia Freitas, et al.
Journal of Virology|January 31, 2020
Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38Akaash K Mishra, Crystal L Moyer, Dafna M Abelson, et al.
Nature Communications|March 26, 2021
Combination therapy protects macaques against advanced Marburg virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spreadFelix Pahmeier, Stephanie R Monticelli, Xinyi Feng, et al.
Pathogens (Basel, Switzerland)|June 24, 2022
Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus ImmunotherapeuticErin Kuang, Robert W Cross, Maria McCavitt-Malvido, et al.
Science Translational Medicine|February 19, 2025
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spreadFelix Pahmeier, Stephanie R Monticelli, Xinyi Feng, et al.
Mbio|April 16, 2025
Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virusAlbert Wang, Stephanie R Monticelli, Ariel S Wirchnianski, et al.
JCI Insight|April 12, 2022
Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Science Translational Medicine|April 3, 2024
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primatesLarry Zeitlin, Robert W Cross, Courtney Woolsey, et al.
Plos Pathogens|April 11, 2024
Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodiesAriel S Wirchnianski, Elisabeth K Nyakatura, Andrew S Herbert, et al.
Pageof 3